Pinnacle Bank boosted its holdings in shares of Danaher Co. (NYSE:DHR) by 52.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 262 shares of the conglomerate’s stock after buying an additional 90 shares during the quarter. Pinnacle Bank’s holdings in Danaher were worth $38,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in DHR. MML Investors Services LLC lifted its holdings in shares of Danaher by 11.2% during the first quarter. MML Investors Services LLC now owns 12,546 shares of the conglomerate’s stock valued at $1,656,000 after purchasing an additional 1,267 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in Danaher during the first quarter worth approximately $554,000. Private Advisor Group LLC grew its stake in Danaher by 44.5% during the first quarter. Private Advisor Group LLC now owns 14,975 shares of the conglomerate’s stock worth $1,976,000 after purchasing an additional 4,612 shares during the period. Banco Santander S.A. acquired a new stake in Danaher during the first quarter worth approximately $312,000. Finally, Permanens Capital L.P. bought a new position in Danaher in the first quarter worth approximately $990,000. 78.42% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NYSE DHR traded up $1.51 during mid-day trading on Wednesday, hitting $137.13. The company had a trading volume of 292,620 shares, compared to its average volume of 2,532,816. The company has a market capitalization of $101.62 billion, a price-to-earnings ratio of 30.34, a P/E/G ratio of 2.37 and a beta of 0.94. Danaher Co. has a 1 year low of $94.59 and a 1 year high of $147.33. The company has a current ratio of 2.32, a quick ratio of 1.91 and a debt-to-equity ratio of 0.33. The stock’s 50-day moving average price is $141.20 and its 200-day moving average price is $137.24.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.15 by $0.04. Danaher had a return on equity of 11.53% and a net margin of 12.22%. The company had revenue of $5.16 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same period in the previous year, the business earned $1.15 earnings per share. The firm’s quarterly revenue was up 3.5% compared to the same quarter last year. As a group, equities research analysts forecast that Danaher Co. will post 4.79 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Friday, September 27th will be paid a $0.17 dividend. The ex-dividend date of this dividend is Thursday, September 26th. This represents a $0.68 annualized dividend and a dividend yield of 0.50%. Danaher’s dividend payout ratio (DPR) is 15.04%.

In other news, insider Thomas Patrick Joyce, Jr. sold 70,544 shares of the company’s stock in a transaction that occurred on Friday, July 19th. The shares were sold at an average price of $141.77, for a total value of $10,001,022.88. Following the transaction, the insider now directly owns 271,023 shares in the company, valued at approximately $38,422,930.71. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Brian W. Ellis sold 1,010 shares of the company’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $144.04, for a total transaction of $145,480.40. Following the completion of the transaction, the insider now owns 20,889 shares in the company, valued at $3,008,851.56. The disclosure for this sale can be found here. In the last three months, insiders sold 177,202 shares of company stock valued at $25,175,829. Corporate insiders own 11.40% of the company’s stock.

Several brokerages have issued reports on DHR. Royal Bank of Canada set a $134.00 price target on Danaher and gave the stock a “hold” rating in a report on Friday, July 19th. ValuEngine downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Wolfe Research set a $157.00 target price on Danaher and gave the stock a “buy” rating in a research report on Thursday, September 26th. Robert W. Baird lifted their price target on Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Finally, Piper Jaffray Companies lifted their price target on Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a research report on Thursday, July 18th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $144.50.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Article: What are the components of an earnings report?

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.